|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics,2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyer MA: Malignant gliomas in adults. N
Engl J Med. 359:18502008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fisher JL, Schwartzbaum JA, Wrensch M and
Wiemels JL: Epidemiology of brain tumors. Neurol Clin. 25:867–890.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yao C, Lv S, Han M, Zhang J, Zhang Y,
Zhang L, Yi R, Zhuang D and Wu J: The association of Crk-like
adapter protein with poor prognosis in glioma patients. Tumor Biol.
35:5695–5700. 2014. View Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Irwandi RA and Vacharaksa A: The role of
microRNA in periodontal tissue: A review of the literature. Arch
Oral Biol. 72:66–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan Y, Shi C, Li T and Kuang T:
microRNA-454 shows anti-angiogenic and anti-metastatic activity in
pancreatic ductal adenocarcinoma by targeting LRP6. Am J Cancer
Res. 7:139–147. 2017.PubMed/NCBI
|
|
10
|
Cao ZG, Li JJ, Yao L, Huang YN, Liu YR, Hu
X, Song CG and Shao ZM: High expression of microRNA-454 is
associated with poor prognosis in triple-negative breast cancer.
Oncotarget. 7:64900–64909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang HL, Hu AP, Li SL, Xie JP, Ma QZ and
Liu JY: miR-454 prompts cell proliferation of human colorectal
cancer cells by repressing CYLD expression. Asian Pac J Cancer
Prev. 16:2397–2402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan Y, Xu LL, Shi CY, Wei W, Wang DS and
Cai DF: MicroRNA-454 regulates stromal cell derived factor-1 in the
control of the growth of pancreatic ductal adenocarcinoma. Sci Rep.
6:227932016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niu G, Li B, Sun J and Sun L: miR-454 is
down-regulated in osteosarcomas and suppresses cell proliferation
and invasion by directly targeting c-Met. Cell Prolif. 48:348–355.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu L, Gong X, Sun L, Yao H, Lu B and Zhu
L: miR-454 functions as an oncogene by inhibiting CHD5 in
hepatocellular carcinoma. Oncotarget. 6:39225–39234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun L, Wang Q, Gao X, Shi D, Mi S and Han
Q: MicroRNA-454 functions as an oncogene by regulating PTEN in
uveal melanoma. FEBS Lett. 589:2791–2796. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang B, Zhu J, Wang Y, Geng F and Li G:
MiR-454 inhibited cell proliferation of human glioblastoma cells by
suppressing PDK1 expression. Biomed Pharmacother. 75:148–152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Richter JD: CPEB: A life in translation.
Trends Biochem Sci. 32:279–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Groisman I, Jung MY, Sarkissian M, Cao Q
and Richter JD: Translational control of the embryonic cell cycle.
Cell. 109:473–483. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ivshina M, Lasko P and Richter JD:
Cytoplasmic polyadenylation element binding proteins in
development, health, and disease. Annu Rev Cell Dev Biol.
30:393–415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Udagawa T, Farny NG, Jakovcevski M,
Kaphzan H, Alarcon JM, Anilkumar S, Ivshina M, Hurt JA, Nagaoka K,
Nalavadi VC, et al: Genetic and acute CPEB1 depletion ameliorate
fragile X pathophysiology. Nat Med. 19:1473–1477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagaoka K, Fujii K, Zhang H, Usuda K,
Watanabe G, Ivshina M and Richter JD: CPEB1 mediates
epithelial-to-mesenchyme transition and breast cancer metastasis.
Oncogene. 35:2893–2901. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shoshan E, Mobley AK, Braeuer RR, Kamiya
T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, et al:
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma
growth and metastasis. Nat Cell Biol. 17:311–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiaoping L, Zhibin Y, Wenjuan L, Zeyou W,
Gang X, Zhaohui L, Ying Z, Minghua W and Guiyuan L: CPEB1, a
histone-modified hypomethylated gene, is regulated by miR-101 and
involved in cell senescence in glioma. Cell Death Dis. 4:e6752013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C((T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu
CW, Wang K, Zheng S, Ng SS, Chan FK, et al: microRNA-139-5p exerts
tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Mol Cancer. 13:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sttg PS: New insights into the tumor
metastatic process revealed by gene expression profiling. Am J
Pathol. 166:1291–1294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du Y, Jiang B, Song S, Pei G, Ni X, Wu J,
Wang S, Wang Z and Yu J: Metadherin regulates actin cytoskeletal
remodeling and enhances human gastric cancer metastasis via
epithelial-mesenchymal transition. Int J Oncol. 51:63–74. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tong L, Chu M, Yan B, Zhao W, Liu S, Wei
W, Lou H, Zhang S, Ma S, Xu J and Wei L: MTDH promotes glioma
invasion through regulating miR-130b-ceRNAs. Oncotarget.
8:17738–17749. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hou Y, Yu L, Mi Y, Zhang J, Wang K and Hu
L: Association of MTDH immunohistochemical expression with
metastasis and prognosis in female reproduction malignancies: A
systematic review and meta-analysis. Sci Rep. 6:383652016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Chen X and Tong M: Knockdown of
astrocyte elevated gene-1 inhibited cell growth and induced
apoptosis and suppressed invasion in ovarian cancer cells. Gene.
616:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu X, Lv Z, Zou J, Liu X, Ma J, Sun C, Sa
N and Xu W: Elevated AEG-1 expression in macrophages promotes
hypopharyngeal cancer invasion through the STAT3-MMP-9 signaling
pathway. Oncotarget. 7:77244–77256. 2016.PubMed/NCBI
|
|
33
|
Skerenova M, Mikulova V, Capoun O, Zima T
and Tesarova P: Circulating tumor cells and serum levels of MMP-2,
MMP-9 and VEGF as markers of the metastatic process in patients
with high risk of metastatic progression. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 161:272–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shin SS, Song JH, Hwang B, Noh DH, Park
SL, Kim WT, Park SS, Kim WJ and Moon SK: HSPA6 augments garlic
extract-induced inhibition of proliferation, migration, and
invasion of bladder cancer EJ cells; Implication for cell cycle
dysregulation, signaling pathway alteration, and transcription
factor-associated MMP-9 regulation. PLoS One. 12:e01718602017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Young RM, Jamshidi A, Davis G and Sherman
JH: Current trends in the surgical management and treatment of
adult glioblastoma. Ann Transl Med. 3:1212015.PubMed/NCBI
|
|
36
|
Krishnatry R, Zhukova N, Guerreiro
Stucklin AS, Pole JD, Mistry M, Fried I, Ramaswamy V, Bartels U,
Huang A, Laperriere N, et al: Clinical and treatment factors
determining long-term outcomes for adult survivors of childhood
low-grade glioma: A population-based study. Cancer. 122:1261–1269.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang X, Zhang X, Hu S, Zheng M, Zhang J,
Zhao J, Zhang X, Yan B, Jia L, Zhao J, et al: Identification of
miRNA-7 by genome-wide analysis as a critical sensitizer for
TRAIL-induced apoptosis in glioblastoma cells. Nucleic Acids Res.
45:5930–5944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiuju C, Zhen W and Yanchao S: SOX7
inhibits tumor progression of glioblastoma and is regulated by
miRNA-24. Open Med (Wars). 11:133–137. 2016.PubMed/NCBI
|
|
39
|
Hu HQ, Sun LG and Guo WJ: Decreased
miRNA-146a in glioblastoma multiforme and regulation of cell
proliferation and apoptosis by target notch1. Int J Biol Markers.
31:e270–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Xin Z, Xu Y and Ma J: Upregulated
miRNA-622 inhibited cell proliferation, motility, and invasion via
repressing kirsten rat sarcoma in glioblastoma. Tumour Biol.
37:5963–5970. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma C, Wei F, Xia H, Liu H, Dong X, Zhang
Y, Luo Q, Liu Y and Li Y: MicroRNA-10b mediates TGF-β1-regulated
glioblastoma proliferation, migration and epithelial-mesenchymal
transition. Int J Oncol. 50:1739–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou L, Qu YM, Zhao XM and Yue ZD:
Involvement of miR-454 overexpression in the poor prognosis of
hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 20:825–829.
2016.PubMed/NCBI
|
|
43
|
Fidler IJ: The pathogenesis of cancer
metastasis the: Seed and soil' hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tabouret E, Boudouresque F, Farina P,
Barrié M, Bequet C, Sanson M and Chinot O: MMP2 and MMP9 as
candidate biomarkers to monitor bevacizumab therapy in highgrade
glioma. Neuro Oncol. 17:1174–1176. 2015. View Article : Google Scholar : PubMed/NCBI
|
